Total Payments
$8,057
2024 Payments
$591.02
Companies
47
Transactions
461
Medicare Patients
4,949
Medicare Billing
$440,398
Payment Breakdown by Category
Food & Beverage$8,005 (99.4%)
Education$52.22 (0.6%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $8,005 | 455 | 99.4% |
| Education | $52.22 | 6 | 0.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $1,521 | 66 | $0 (2024) |
| ABBVIE INC. | $1,258 | 70 | $0 (2024) |
| Amgen Inc. | $595.40 | 33 | $0 (2024) |
| PFIZER INC. | $538.19 | 40 | $0 (2024) |
| GlaxoSmithKline, LLC. | $473.86 | 27 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $378.59 | 16 | $0 (2022) |
| Janssen Pharmaceuticals, Inc | $323.95 | 24 | $0 (2021) |
| Merck Sharp & Dohme LLC | $312.60 | 21 | $0 (2023) |
| SANOFI PASTEUR INC. | $288.94 | 11 | $0 (2024) |
| Novo Nordisk Inc | $268.80 | 24 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $591.02 | 30 | ABBVIE INC. ($238.79) |
| 2023 | $1,420 | 73 | ABBVIE INC. ($438.19) |
| 2022 | $1,560 | 87 | ABBVIE INC. ($345.72) |
| 2021 | $1,148 | 60 | AstraZeneca Pharmaceuticals LP ($249.86) |
| 2020 | $375.08 | 23 | AstraZeneca Pharmaceuticals LP ($116.94) |
| 2019 | $770.64 | 48 | AstraZeneca Pharmaceuticals LP ($192.01) |
| 2018 | $963.43 | 60 | AstraZeneca Pharmaceuticals LP ($211.31) |
| 2017 | $1,229 | 80 | AstraZeneca Pharmaceuticals LP ($307.46) |
All Payment Transactions
461 individual payment records from CMS Open Payments — Page 1 of 19
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 06/04/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $12.56 | General |
| Category: NEUROSCIENCE | ||||||
| 05/31/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $7.98 | General |
| Category: NEUROSCIENCE | ||||||
| 05/30/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $22.31 | General |
| Category: Obesity | ||||||
| 05/30/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $13.33 | General |
| Category: Diabetes | ||||||
| 05/30/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $11.13 | General |
| Category: NEUROSCIENCE | ||||||
| 05/29/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $29.22 | General |
| Category: Inflammation | ||||||
| 05/22/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $17.54 | General |
| Category: NEUROSCIENCE | ||||||
| 05/17/2024 | GlaxoSmithKline, LLC. | SHINGRIX (Biological) | Food and Beverage | In-kind items and services | $16.83 | General |
| Category: VACCINES | ||||||
| 05/10/2024 | Lilly USA, LLC | JARDIANCE (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $16.85 | General |
| Category: Diabetes | ||||||
| 05/10/2024 | PFIZER INC. | PAXLOVID (Drug) | Food and Beverage | In-kind items and services | $16.12 | General |
| Category: INFECTIOUS DISEASES | ||||||
| 05/09/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $6.15 | General |
| Category: NEUROSCIENCE | ||||||
| 04/21/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $6.02 | General |
| Category: NEUROSCIENCE | ||||||
| 04/12/2024 | Lilly USA, LLC | JARDIANCE (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $15.48 | General |
| Category: Diabetes | ||||||
| 04/12/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $12.23 | General |
| Category: NEUROSCIENCE | ||||||
| 04/11/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $26.02 | General |
| Category: NEUROSCIENCE | ||||||
| 04/09/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $22.71 | General |
| Category: PSYCHIATRY | ||||||
| 04/05/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $25.59 | General |
| Category: Oncology | ||||||
| 03/28/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $24.00 | General |
| Category: NEUROSCIENCE | ||||||
| 03/27/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $17.20 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 03/20/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $26.47 | General |
| Category: Bone Health | ||||||
| 03/14/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $17.87 | General |
| Category: NEUROSCIENCE | ||||||
| 03/08/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $22.22 | General |
| Category: NEUROSCIENCE | ||||||
| 03/06/2024 | SANOFI PASTEUR INC. | BEYFORTUS (Biological), MENQUADFI, FLUZONE QUADRIVALENT NORTHERN HEMISPHERE | Food and Beverage | In-kind items and services | $48.62 | General |
| Category: Vaccines | ||||||
| 02/21/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $25.56 | General |
| Category: Inflammation | ||||||
| 02/09/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $22.30 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 871 | 1,252 | $148,578 | $103,739 |
| 2022 | 19 | 1,283 | 1,851 | $151,784 | $106,463 |
| 2021 | 20 | 1,485 | 2,078 | $180,137 | $133,661 |
| 2020 | 19 | 1,310 | 1,827 | $144,250 | $96,536 |
Total Patients
4,949
Total Services
7,008
Medicare Billing
$440,398
Procedure Codes
70
All Medicare Procedures & Services
70 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 381 | 684 | $89,304 | $59,472 | 66.6% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 136 | 136 | $19,813 | $17,876 | 90.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 155 | 181 | $17,092 | $10,285 | 60.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 54 | 68 | $12,565 | $8,618 | 68.6% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2023 | 20 | 20 | $3,724 | $3,354 | 90.1% |
| 90732 | Pneumococcal vaccine, 23-valent | Office | 2023 | 12 | 12 | $1,511 | $1,481 | 98.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 13 | 13 | $2,903 | $1,209 | 41.6% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 44 | 69 | $669.99 | $656.88 | 98.0% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 14 | 14 | $282.24 | $283.06 | 100.3% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 11 | 23 | $334.88 | $253.88 | 75.8% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 17 | 18 | $330.99 | $202.25 | 61.1% |
| 81002 | Urinalysis, manual test | Office | 2023 | 14 | 14 | $48.72 | $47.74 | 98.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 386 | 634 | $83,029 | $51,270 | 61.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 114 | 114 | $16,596 | $15,033 | 90.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 180 | 225 | $20,963 | $13,833 | 66.0% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 118 | 118 | $7,196 | $7,055 | 98.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 24 | 25 | $4,593 | $3,125 | 68.0% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 126 | 127 | $2,179 | $2,162 | 99.2% |
| 0124A | Fee covid-19 vac 13 res | Office | 2022 | 53 | 53 | $2,423 | $2,100 | 86.7% |
| 0064A | Adm sarscov2 50mcg/0.25mlbst | Office | 2022 | 47 | 47 | $2,115 | $1,882 | 89.0% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2022 | 11 | 11 | $2,468 | $1,861 | 75.4% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2022 | 11 | 11 | $2,427 | $1,789 | 73.7% |
| 90732 | Pneumococcal vaccine, 23-valent | Office | 2022 | 13 | 13 | $1,637 | $1,617 | 98.8% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 20 | 163 | $2,371 | $1,616 | 68.1% |
| 0054A | Adm sarscv2 30mcg trs-sucr b | Office | 2022 | 35 | 35 | $1,575 | $1,398 | 88.8% |
About Dr. Matthew Lawrence, MD
Dr. Matthew Lawrence, MD is a Family Medicine healthcare provider based in Richland, Washington. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/25/2005. The National Provider Identifier (NPI) number assigned to this provider is 1255324109.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Matthew Lawrence, MD has received a total of $8,057 in payments from pharmaceutical and medical device companies, with $591.02 received in 2024. These payments were reported across 461 transactions from 47 companies. The most common payment nature is "Food and Beverage" ($8,005).
As a Medicare-enrolled provider, Lawrence has provided services to 4,949 Medicare beneficiaries, totaling 7,008 services with total Medicare billing of $440,398. Data is available for 4 years (2020–2023), covering 70 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Richland, WA
- Active Since 08/25/2005
- Last Updated 07/08/2007
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1255324109
Products in Payments
- FARXIGA (Drug) $930.56
- UBRELVY (Drug) $538.47
- QULIPTA (Drug) $519.51
- JARDIANCE (Drug) $362.49
- NURTEC ODT (Drug) $329.30
- XARELTO (Drug) $298.07
- SHINGRIX (Biological) $290.42
- BREZTRI (Drug) $232.58
- CHANTIX (Drug) $203.62
- Aimovig (Biological) $187.56
- Otezla (Drug) $186.85
- Cologuard Collection Kit (Device) $172.35
- BEXSERO (Biological) $163.67
- BEYFORTUS (Biological) $145.26
- EVENITY (Biological) $121.55
- Kerendia (Drug) $121.42
- ELIQUIS (Drug) $120.72
- GARDASIL 9 (Biological) $108.29
- LINZESS (Drug) $108.19
- QELBREE (Drug) $98.63
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Richland
Douglas Crawford, D.o, D.O
Family Medicine — Payments: $17,572
Family Medicine $17,572
Martin Coker, M.d, M.D
Family Medicine — Payments: $10,688
Family Medicine $10,688
Dr. Douglas Hargrave, D.o, D.O
Family Medicine — Payments: $8,275
Family Medicine $8,275
Dr. Scott Kelly, M.d, M.D
Family Medicine — Payments: $4,838
Family Medicine $4,838
David Merkley, Md, MD
Family Medicine — Payments: $3,884
Family Medicine $3,884
Dr. James Polk, M.d, M.D
Family Medicine — Payments: $3,668
Family Medicine $3,668